In vitro selection of high level quinoxaline (HBY097) resistance using a patient isolate displaying a multidrug resistant phenotype

Anne‐Mieke Vandamme; JC Schmit; Jan Balzarini; Myriam Witvrouw; K VanLaethem; J. Kleim; Jan Desmyter; De Clercq Erik

Back

In vitro selection of high level quinoxaline (HBY097) resistance using a patient isolate displaying a multidrug resistant phenotype

Article 1996 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1999

In vitro selection of high level resistance towards foscarnet and acyclic nucleoside phosphonates using a patient isolate displaying the multinucleoside resistant pattern

Kristel Van Laethem, Myriam Witvrouw, Jan Balzarini, Christophe Pannecouque, R. Esnouf, JC Schmit, P Hermans, Marc Van Ranst, Jan Desmyter, De Clercq Erik, Anne‐Mieke Vandamme

Article1997

The combined presence of the quinoxaline HBY097 and 3TC results in potent suppression of AZT-resistant HIV-1 strains

Jan Balzarini, Heidi Pelemans, G Riess, Manfred Roesner, Irvin Winkler, De Clercq Erik, J P Kleim

Article2007

A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens

Hui‐Qin Tang, Christine M.N. Yow, Michael R Hamblin

Article1992

High-Dose Mefloquine in the Treatment of Multidrug-Resistant Falciparum Malaria

Feiko O. ter Kuile, François Nosten, M. Thieren, C. Luxemburger, Michael D. Edstein, T Chongsuphajaisiddhi, L Phaipun, H. Kyle Webster, Sir Nicholas White

The Journal of Infectious Diseases

Article2025

Genome-level selection in tumors as a universal marker of resistance to therapy

Erez Persi, Praneeth Sudalagunta, Yuri I. Wolf, Rafael Renatino Canevarolo, Mehdi Damaghi, Kenneth H. Shain, Ariosto S. Silva, Eugene V Koonin